M&A Deal Summary |
|
|---|---|
| Date | 2013-10-28 |
| Target | Systagenix Wound Management |
| Sector | Medical Products |
| Buyer(s) | Kinetic Concepts |
| Sellers(s) | One Equity Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 485M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Medical Products |
Kinetic Concepts, Inc. is a developer and marketer of an innovative medical devices for advanced wound healing and therapeutic treatment systems that address skin breakdown, pulmonary complications, and circulation problems associated with patient immobility. KCI's medical devices and therapeutic systems include V.A.C.® Therapy Systems, as well as specialty beds, mattress replacement systems, wheelchair seating, and related devices. KCI serves hospitals, nursing homes, and home care settings both in the U.S. and abroad.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Medical Products) | 2 of 2 |
| Type (Add-on Acquisition) | 2 of 2 |
| Country (United Kingdom) | 1 of 1 |
| Year (2013) | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-04-01 |
LifeCell
Branchburg, New Jersey, United States LifeCell Corp. is a provider of applications in plastic and reconstructive surgeries and abdominal wall procedures. |
Buy | $170M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-09-03 |
Systagenix Wound Management
Gatwick, United Kingdom Systagenix Wound Management Ltd. is a provider of advanced wound care market and develops, manufactures and markets products in approximately 50 countries worldwide. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 10.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
One Equity Partners (OEP) is a private equity firm that targets buyout and growth capital investments in North America, Europe, and Asia. OEP prefers to be the lead investor and typically commits $30 to $300 million per transaction. Sectors of interest include industrial products/services, consumer, retail, chemicals, media, communications, and healthcare. One Equity Partners was formed in 2001 and spun out of JP Morgan Chase in 2015. One Equity Partners is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 20 of 55 |
| Sector (Medical Products) | 2 of 4 |
| Type (Add-on Acquisition) | 15 of 35 |
| Country (United Kingdom) | 1 of 2 |
| Year (2013) | 3 of 4 |
| Size (of disclosed) | 17 of 20 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-10-07 |
Chemlogics Group
Paso Roble, California, United States Chemlogics provides the energy sector with specialty chemicals used in the extraction and production of oil and gas. |
Sell | $1.3B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-13 |
PeroxyChem
Philadelphia, Pennsylvania, United States PeroxyChem LLC is a provider in peroxygen and adjacent chemistries with facilities in North America, Europe, and Asia. PeroxyChem manufactures high-quality products and innovative applications developed as a result of ingenuity and technical expertise. PeroxyChem LLC is based in Philadelphia, Pennsylvania. |
Buy | $200M |
